P2RX7 and Alzheimer disease: Importantly, in an AD neuroinflammation model, the KO of the P2X7 receptor significantly decreased the CCL3 chemokine release (Martin et al., 2019), indicating that the activation of this receptor may contribute to this inflammatory aspect of MS.